Company / Profit Margin
Edwards Lifesciences Profit Margin History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
17.7%
FY2025
5-year range
17.7% / 76.8%
FY2021-FY2025
Trend
-77.0%
vs FY2024
Sector context
#17 of 156
Health Care
What the data says
Edwards Lifesciences's profit margin of 17.7% is higher than 89% of companies in the Health Care sector (FY2025). Profit Margin has fluctuated over the past 5 years, ranging from 17.7% in FY2025 to 76.8% in FY2024.
Based on SEC 10-K filings.
17.7% in FY2025 with a 3-year CAGR of -16.4%. Top quartile in the Health Care sector.
Declined from 28.7% to 17.7% over the past 2 years.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- -16.4pp
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
Top 11% in Health CareTop 11% of 156This company 17.7% Sector average -252.5%
▼
+107.0% above sector average
Key checks
Key Insights
- In FY2025, profit margin decreased 77.0% year-over-year.
- Currently 270.2pp above the Health Care sector average.
- Peak profit margin was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 3.16 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 17.7% | -77.0% |
| FY2024 | 76.8% | +167.1% |
| FY2023 | 28.7% | -15.7% |
| FY2022 | 34.1% | +18.7% |
| FY2021 | 28.7% | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026